Efficacy of bepotastine besilate for seasonal allergic rhinitis patients - about laryngeal symptoms, olfactory disorder, sleep disorder, QOL and symptoms caused by Asian sand dust

Efficacy of bepotastine besilate for seasonal allergic rhinitis patients - about laryngeal symptoms, olfactory disorder, sleep disorder, QOL and symptoms caused by Asian sand dust - Efficacy of bepotastine besilate for seasonal allergic rhinitis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013625

Enrollment

Registered

2014-04-04

Start date

2014-01-15

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Seasonal allergic rhinitis

Interventions

Bepotastine besilate

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: Patients with using any other antiallergic medicine or immunotherapy.

Design outcomes

Primary

Measure	Time frame
Nasal symptoms, nasal findings, laryngeal symptoms, laryngeal findings, olfactory disorder, sleep disorder, QOL, and symptoms caused by Asian sand dust	—

Countries

Japan

Contacts

Public ContactTomoaki Murashima

Fujita Health University Otorhinoralyngology

abc2-and@fujita-hu.ac.jp0562-93-9291

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026